ECM is required for skeletal muscle differentiation independently of muscle regulatory factor expression

Research output: Contribution to journalArticlepeer-review

120 Scopus citations

Abstract

Transcription of specific skeletal muscle genes requires the expression of the muscle regulatory factor myogenin. To assess the role of the extracellular matrix (ECM) in skeletal muscle differentiation, the specific inhibitors of proteoglycan synthesis, sodium chlorate and β-D-xyloside, were used. Treatment of cultured skeletal muscle cells with each inhibitor substantially abolished the expression of creatine kinase and α-dystroglycan. This inhibition was totally reversed by the addition of exogenous ECM. Myoblast treatment with each inhibitor affected the deposition and assembly of the ECM constituents glypican, fibronectin, and laminin. These treatments did not affect MyoD, MEF2A, and myogenin expression and nuclear localization. Differentiated myoblast treatment with RGDS peptides completely inhibited myogenesis without affecting the expression or nuclear localization of myogenin. Integrin-mediated signaling of focal adhesion kinase was partially inhibited by chlorate and β-D-xyloside, an effect reversed by the addition of exogenous ECM gel. These results suggested that the expression of myogenin is not sufficient to successfully drive skeletal muscle formation and that ECM is required to complete the skeletal muscle differentiation process.

Original languageEnglish
JournalAmerican Journal of Physiology - Cell Physiology
Volume282
Issue number2 51-2
StatePublished - 2 Jul 2002

Keywords

  • Extracellular matrix
  • Myogenin
  • Proteoglycan inhibitors
  • Proteoglycans
  • Satellite cells

Fingerprint Dive into the research topics of 'ECM is required for skeletal muscle differentiation independently of muscle regulatory factor expression'. Together they form a unique fingerprint.

Cite this